Skip to main content
. 2021 Sep 20;12:745939. doi: 10.3389/fimmu.2021.745939

Figure 7.

Figure 7

Tumor-experienced NK cells inhibit CD8+ T cell proliferation through PD-L1. (A) Experimental design used to generate control NK cells (NKcontrol ) and tumor-experienced NK cells enriched in PD-L1hi cells (NKte ) to investigate their effect on T cell proliferation. (B) Relative proliferation of CD8+ T cells analyzed by CFSE dilution after stimulation with anti-CD3/anti-CD28 mAb and cultured with increasing numbers of autologous NKcontrol or NKte . (C) Relative proliferation of CD8+ T cells analyzed by CFSE dilution after stimulation with anti-CD3/anti-CD28 mAb in the absence or in the presence of autologous NKcontrol or NKte in the absence or in the presence of an anti-PD-L1 blocking mAb. Representative histograms showing CFSE dilution in live CD3+CD8+CD56- cells are shown (n=3). Data represent mean ± SEM. Two-way ANOVA with Sidak´s post hoc test (B) and one-way ANOVA and Tukey´s post hoc test (C) *p<0.05, **p<0.01, *** p<0.001.